Biotech unicorn Ginkgo Bioworks is one of a new class of startups exploring the capabilities of synthetic biology. The company is now worth $4 billion after securing $290 million in additional funding.
When a company begins the merger and acquisition (M&A) process, the odds are not in its favor — some 70 to 90 percent of all M&A fail. Despite these odds, however, nearly 13,000 deals closed in 2018, many of which received some help from fintech firm SS&C Intralinks.
For developers, side projects are a chance to experiment with something new and hone their skills. Even though those experiments don’t always start as a business need, the products (and experiences) tend to make themselves useful at some point. Three Boston developers told us how their side projects make a difference in their day jobs.
Vendr aims to fix the “epically inefficient” B2B sales industry, providing a way to speed up transactions while lowering purchase costs. The company is now hiring, and plans to use this fresh funding to fuel product development and expand its presence internationally.
AllHere’s chatbot is the first of its kind on the K-12 space. It is designed to helps schools improve student grades and attendance, which has become a pressing issue amid the Covid-19 pandemic.
